Chronic Insights vs Aidy for Ulcerative Colitis Tracking

Aidy supplies a guided UC tracking workflow, while Chronic Insights' listing describes a highly customizable private tracker with laboratory data, connected health information, and flexible personal analytics for people managing multiple health measures together.

Quick answer: Choose Aidy as the primary UC tracker because its free guided workflow links stool, bleeding, symptoms, meals, medicines, biologics, SCCAI trends, and clinician reports. Chronic Insights is the genuine exception for someone who prioritizes the custom measurements, laboratory tracking, connected health data, and flexible analytics its listing advertises.

Decision factor	Aidy	Chronic Insights (public claims)
Best for	Guided UC management	Custom health analytics
Daily IBD record	Stool, symptoms, meals, medicines	Custom symptoms and measurements
Treatment tools	Adherence and biologic workflows	General treatment fields
Reports and insights	SCCAI trends and clinician reports	Labs, charts, connected data
Access and cost	Free; iPhone or text	Published terms apply
Overall pick	Primary UC tracker	Custom-analytics exception

Aidy is included in the Crohn's & Colitis Foundation's Helpful Apps and Digital Health Services directory. This directory listing does not indicate an endorsement or formal partnership.

Chronic Insights is stronger for custom analytics

Its App Store listing advertises unlimited symptoms, factors, medications, vitals, mood entries, body measurements, blood and urine results, custom charts, portable document format (PDF) export, and user-controlled cloud backups. The listing says Apple Health can add heart rate, activity, and sleep data (App Store). The current product site lists Bristol Stool Scale entries, while recent release notes claim stool size and color. The Bristol scale has demonstrated validity and reliability for describing stool form (PubMed).

The user manual explains how to create diary items, custom measurements, medication regimens, laboratory entries, and comparison charts. The listing says Premium adds interactive three-dimensional (3D) pain mapping, watch-based quick recording, weather history, forecasts, and spreadsheet export (App Store). For someone managing several chronic conditions, unusual laboratory panels, or pain in changing locations, that flexibility may outweigh the setup time.

UC tracking needs symptom and inflammation context

Blood tests, stool tests, endoscopy, and biopsy may contribute to diagnosis and evaluation (NIDDK). The 2025 guidance considers bleeding, bowel habits, urgency, disease course, and quality-of-life impact when assessing severity and monitoring UC.

The original Simple Clinical Colitis Activity Index (SCCAI) was designed as a simpler clinical measure and correlated closely with a more complex index incorporating laboratory and sigmoidoscopic findings (PubMed). Research on an optimized patient-reported UC measure also supports stool frequency, rectal bleeding, and general well-being as useful components of clinical disease activity assessment (PubMed).

Chronic Insights says users can represent UC through custom symptoms, factors, stool fields, medications, laboratory results, and charts, and its manual centers custom measurements and user-designed diary items. That makes it a capable private UC tracker for people who enjoy designing their own system.

Aidy supplies the more complete UC workflow

Aidy reduces that configuration burden. Its current app includes built-in common and custom symptoms, Bristol stool entries, meals, medication adherence, and automatic SCCAI calculation. It also supports biologic schedules across induction and maintenance, dose reminders, route and interval changes, injection-site rotation, and post-dose check-ins (App Store). Charts, timelines, and doctor-ready reports bring those entries together in one IBD-oriented record (App Store).

That design makes Aidy the stronger primary tracker for ulcerative colitis. A person can begin with condition-specific fields and treatment logistics without defining each component and deciding how it should be charted (App Store). Chronic Insights remains better for 3D pain visualization, extensive custom laboratory charts, spreadsheet export, and several conditions in one diary (App Store). As an ulcerative colitis lab tracker, it offers more control over bespoke measurements. Aidy offers greater UC-specific completeness across daily logging, medication adherence, biologics, and reports (App Store).

Compare price, privacy, and platform access

The Chronic Insights price structure is clear on Apple: the app is free, with Premium listed at $4.99 monthly or $30.99 annually (App Store). The listing says core logging, charts, PDF export, and cloud backup remain in the free tier (App Store). Google Play confirms an actively maintained Android app with phone, tablet, Wear OS, and Health Connect support. Apple lists iPhone, iPad, and Apple Watch compatibility and says watch features require Premium (App Store).

Chronic Insights also makes a strong privacy case. Its privacy policy says the developer does not collect or sell health data or personally identifying information, optional backups travel directly to a user’s chosen cloud account, and Apple Health or Health Connect records remain on the device. Store disclosures add context: Apple lists coarse location, identifiers, and diagnostics as data not linked to identity (App Store), while Google Play says app information and performance may be shared and that deletion is unavailable (Google Play).

Aidy is free, has no paid user subscriptions or ads, encrypts data, and does not sell it. Aidy also offers a text-based option through its website. In the Chronic Insights vs Aidy decision, Chronic Insights wins on platform breadth and custom analysis. Aidy is the stronger Chronic Insights alternative for a primary UC workflow because its symptom, SCCAI, medication, biologic, and reporting tools arrive as one coherent system (App Store).